JP MORGAN/CALL/BECTON DICKINSON AND CO./250/0.1/17.01.25 Share Price

Warrant

DE000JL1KNS7

Market Closed - Bid/Ask 12:47:37 17/06/2024 pm IST After market 12:30:01 am
1.86 EUR +8.77% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./250/0.1/17.01.25 1.815 -2.42%
Current month+10.32%
1 month-21.20%
Date Price Change
17/24/17 1.86 +8.77%
14/24/14 1.71 -6.56%
13/24/13 1.83 -3.68%
12/24/12 1.9 -11.21%
11/24/11 2.14 +0.47%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 12:47 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNS
ISINDE000JL1KNS7
Date issued 05/04/2023
Strike 250 $
Maturity 17/01/2025 (214 Days)
Parity 10 : 1
Emission price 3.33
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.69
Lowest since issue 1.36
Delta0.48x
Omega 5.649
Premium15.63x
Gearing11.73x
Moneyness 0.9337
Difference Strike 17.47 $
Difference Strike %+6.99%
Spread 0.03
Spread %1.60%
Theoretical value 1.815
Implied Volatility 34.14 %
Total Loss Probability 62.12 %
Intrinsic value 0.000000
Present value 1.815
Break even 269.49 €
Theta-0.04x
Vega0.07x
Rho0.05x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus